Novel Insight Into Migraine Pathophysiolgy and Galcanezumab Mechanisms of Action

Clinical trial NCT04271202 · COMPLETED

Trial details

NCT number: NCT04271202
Sponsor: Beth Israel Deaconess Medical Center
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Chronic Migraine

Start date: 2020-07-29
Primary completion: 2023-11-22
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.